Previous Section
Drug Therapy
8. The outcome of intensive induction therapy in patients >/=70 years with acute myeloid leukemia.
- Author
- Gupta V; Xu W; Keng C; Alibhai SM; Brandwein J; Schimmer A; Schuh A; Yee K; Minden MD;
- Institution
- 1Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
- Journal
- Leukemia. 2007 Mar 8;.
9. Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.
- Author
- Specchia G; Pastore D; Carluccio P; Spinosa G; Giannoccaro M; Rizzi R; Mestice A; Liso V;
- Institution
- Hematology Section, DAP, University of Bari, Piazza G. Cesare 11, 70124, Bari, Italy, g.specchia@ematba.uniba.it.
- Journal
- Ann Hematol. 2007 Jun;86(6):425-8. Epub 2007 Mar 16.
- Abstract URL
- Click here to view abstract
10. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.
- Author
- Qian SX; Li JY; Tian T; Shen YF; Jiang YQ; Lu H; Wu HX; Zhang SJ; Xu W;
- Institution
- Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing 210029, China.
- Journal
- Leuk Res. 2007 Apr 7;.
- Abstract URL
- Click here to view abstract
11. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.
- Author
- Etienne A; Esterni B; Charbonnier A; Mozziconacci MJ; Arnoulet C; Coso D; Puig B; Gastaut JA; Maraninchi D; Vey N;
- Institution
- Department of Hematology, Paoli-Calmettes Institute, Marseille, France.
- Journal
- Cancer. 2007 Apr 1;109(7):1376-83.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
